Autres langues Takeda Pharmaceutical Company Limited

Actions

4502

JP3463000004

Produits pharmaceutiques

Temps Différé Japan Exchange 08:00:41 02/10/2026			Varia. 5j.	Varia. 1 janv.
5 651,00 ^JPY	-1,40%		-5,31%	+16,90%

30/09	Les actions asiatiques négociées aux États-Unis sous forme de certificats américains de dépôt progressent modestement mercredi	MT
30/09	Takeda annonce que son nouveau traitement contre le psoriasis a surpassé celui d’un concurrent dans une étude de phase 3	MT

Autres langues

30/09	Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading
30/09	Takeda Reports New Psoriasis Treatment Outperformed Competitor in Phase 3 Trial
30/09	Takeda Pharmaceutical Company Limited Announces New Phase 3 Head-To-Head Results for Zasocitinib
30/09	Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill
29/09	Keros Therapeutics Expects $20 Million Milestone Payment From Takeda
29/09	Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium
29/09	Pharma sector doubles down on AI to slash costs, timelines
23/09	Two announcments for Roche
23/09	Aktien Schweiz Vorbörse: SMI freundlich erwartet - Nahosthoffnungen und Ölpreis
23/09	Roche proposes former Takeda CEO for board seat
23/09	Roche schlägt Christophe Weber zur Wahl in den Verwaltungsrat vor
22/09	Takeda Pharmaceutical Company Limited Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research Led by Phase 3 Arcotatug Tavatecan Data At Esmo 2026
22/09	Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026
21/09	Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
21/09	Pharma sector doubles down on AI to slash costs, timelines
21/09	Takeda Announces Appointment of Enrique Vázquez as Head of Public Affairs in Spain
18/09	Dr. Reddy's, Takeda Sign Deal to Distribute QDENGA Dengue Vaccine in India
18/09	Dr. Reddy's Enters Agreement to Bring Takeda's Dengue Vaccine to India
18/09	Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems
18/09	Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine
16/09	Pharma sector doubles down on AI to slash costs, timelines
14/09	Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Monday Trading
14/09	U.S. FDA Grants Priority Review to Takeda Pharmaceutical's Zasocitinib NDA for Plaque Psoriasis
14/09	Takeda's Investigational Plaque Psoriasis Drug Accepted for Priority Review by US FDA
14/09	Takeda Pharmaceutical Company Limited Receives U.S. FDA Acceptance Of New Drug Application Under Priority Review For Zasocitinib In Moderate-To-Severe Plaque Psoriasis